Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸氨溴索颗粒 - NMPA Drug Approval Details

Approvals/NMPA/Ambroxol Hydrochloride Granules

Approved

化学药品

Ambroxol Hydrochloride Granules

山东科成医药科技有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 22, 2023
Approval ID: 8VFT5usV3Ve
Company: 山东科成医药科技有限公司
Type: 化学药品

Approval Details

Approval Id: 8VFT5usV3Ve
Approval Number: 国药准字H20230026
Generic Name: 盐酸氨溴索颗粒
Generic Name En: Ambroxol Hydrochloride Granules
Drug Type: 化学药品
Dosage Form: 颗粒剂
Strength: 15mg
Reg Date: 2023-12-22
Company Name: 山东科成医药科技有限公司
Company Address: 菏泽市开发区长江东路2999号本草大厦7层
Production Company Name: 上海医药集团（本溪）北方药业有限公司
Production Company Address: 辽宁省本溪经济技术开发区（石桥子）神农大街22号
Company Detail Path: /organization/b5b943bb9b02e5c0/shan-dong-ke-cheng-yi-yao-ke-ji-you-xian-gong-si
Production Company Detail Path: /organization/3291cf6d418c7207/shang-hai-yi-yao-ji-tuan-ben-xi-bei-fang-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 22, 2023

Approval ID

8VFT5usV3Ve

Type

化学药品

Back to NMPA Approvals